Polypoidal Choroidal Vasculopathy: Outer Retinal and Choroidal Changes and Neovascularization Development in the Fellow Eye

Invest Ophthalmol Vis Sci. 2019 Feb 1;60(2):590-598. doi: 10.1167/iovs.18-24244.

Abstract

Purpose: We investigated the outer retinal, RPE, and choroidal changes and the development of choroidal neovascularization (CNV) in fellow eyes of patients with unilateral polypoidal choroidal vasculopathy or aneurysmal type 1 neovascularization (PCV/AT1).

Methods: In this retrospective observational cohort study, 263 patients with unilateral PCV/AT1 were enrolled. Fundus photography, enhanced depth imaging optical coherence tomography, and indocyanine green angiography at baseline and follow-up were analyzed. Incidence and risk factors for the development of CNV were analyzed.

Results: In fellow eyes of unilateral PCV/AT1 cases, RPE and outer retinal abnormalities were observed in 222 (84%) eyes, and dilated Haller vessels (pachyvessel) were identified in the corresponding abnormality area in 157 (71%) eyes. Follow-up data were available for 233 patients. During a 27.6-month mean follow-up period, 20/233 (9%) eyes had CNV (12 PCV/AT1 and eight type 1 CNV). In 18 eyes (90%), CNV developed at the RPE or outer retinal abnormality areas accompanied by pachyvessel. A significantly higher risk for CNV was observed if RPE and outer retinal abnormalities were accompanied by pachyvessel (hazard ratio, 9.3; 95% confidence interval, 1.1-75.9, P = 0.037).

Conclusions: RPE and outer retinal abnormalities were common in fellow eyes of patients presenting with unilateral PCV/AT1. CNV developed in fellow eyes of 9% of patients, frequently in the areas with RPE and outer retinal abnormality accompanied by pachyvessel.

MeSH terms

  • Adult
  • Aged
  • Aged, 80 and over
  • Choroid / blood supply*
  • Choroidal Neovascularization / diagnosis*
  • Choroidal Neovascularization / physiopathology
  • Cohort Studies
  • Coloring Agents / administration & dosage
  • Female
  • Fluorescein Angiography / methods
  • Follow-Up Studies
  • Humans
  • Incidence
  • Indocyanine Green / administration & dosage
  • Male
  • Middle Aged
  • Polyps / diagnosis*
  • Polyps / physiopathology
  • Retinal Diseases / diagnosis*
  • Retinal Pigment Epithelium / pathology*
  • Retrospective Studies
  • Risk Factors
  • Tomography, Optical Coherence / methods

Substances

  • Coloring Agents
  • Indocyanine Green